Sonnet Property Plant And Equipment Net from 2010 to 2024

SONN Stock  USD 2.57  0.06  2.28%   
Sonnet Biotherapeutics Property Plant And Equipment Net yearly trend continues to be very stable with very little volatility. Property Plant And Equipment Net is likely to grow to about 10.2 M this year. Property Plant And Equipment Net is the total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects Sonnet Biotherapeutics' investment in assets used for production. View All Fundamentals
 
Property Plant And Equipment Net  
First Reported
2006-06-30
Previous Quarter
186.6 K
Current Value
165.5 K
Quarterly Volatility
8.2 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Sonnet Biotherapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sonnet Biotherapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.3 M, Interest Expense of 2.4 M or Selling General Administrative of 2.4 M, as well as many indicators such as Price To Sales Ratio of 1.12, Dividend Yield of 0.0 or PTB Ratio of 5.12. Sonnet financial statements analysis is a perfect complement when working with Sonnet Biotherapeutics Valuation or Volatility modules.
  
Check out the analysis of Sonnet Biotherapeutics Correlation against competitors.

Latest Sonnet Biotherapeutics' Property Plant And Equipment Net Growth Pattern

Below is the plot of the Property Plant And Equipment Net of Sonnet Biotherapeutics Holdings over the last few years. It is the total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production. Sonnet Biotherapeutics' Property Plant And Equipment Net historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Sonnet Biotherapeutics' overall financial position and show how it may be relating to other accounts over time.
Property Plant And Equipment Net10 Years Trend
Very volatile
   Property Plant And Equipment Net   
       Timeline  

Sonnet Property Plant And Equipment Net Regression Statistics

Arithmetic Mean5,893,641
Geometric Mean2,131,735
Coefficient Of Variation91.81
Mean Deviation4,756,333
Median5,620,189
Standard Deviation5,411,195
Sample Variance29.3T
Range16.6M
R-Value0.05
Mean Square Error31.4T
R-Squared0
Significance0.85
Slope62,993
Total Sum of Squares409.9T

Sonnet Property Plant And Equipment Net History

202410.2 M
2022227.1 K
2021302.8 K
2020182.3 K
2019273.8 K
20189.8 M
201710.5 M

About Sonnet Biotherapeutics Financial Statements

Sonnet Biotherapeutics investors utilize fundamental indicators, such as Property Plant And Equipment Net, to predict how Sonnet Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Property Plant And Equipment Net9.8 M10.2 M
When determining whether Sonnet Biotherapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sonnet Biotherapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sonnet Biotherapeutics Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sonnet Biotherapeutics Holdings Stock:
Check out the analysis of Sonnet Biotherapeutics Correlation against competitors.
You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sonnet Biotherapeutics. If investors know Sonnet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sonnet Biotherapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.96)
Revenue Per Share
0.019
Quarterly Revenue Growth
(0.50)
Return On Assets
(0.97)
Return On Equity
(2.65)
The market value of Sonnet Biotherapeutics is measured differently than its book value, which is the value of Sonnet that is recorded on the company's balance sheet. Investors also form their own opinion of Sonnet Biotherapeutics' value that differs from its market value or its book value, called intrinsic value, which is Sonnet Biotherapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sonnet Biotherapeutics' market value can be influenced by many factors that don't directly affect Sonnet Biotherapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sonnet Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sonnet Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sonnet Biotherapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.